Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV versus gargled lidocaine + remifentanil for extubation response attenuation
IRCT20141209020258N172Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in general anesthesia comparing Gargled lidocaine + remifentanil mixture with Intravenous remifentanil (2 arms). Primary endpoints: Sore throat, Cough and 2 more. Started Feb 2022; status: completed.
02
Drugs
lidocaineremifentanil
03
Conditions
general anesthesia
Beyond the preview
Go deeper on IRCT20141209020258N172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N172.